|View printer-friendly version|
|June 09, 2004 5:06 p.m.|
|Teva Announces Approval Of Ciprofloxacin Tablets|
Jerusalem, Israel, June 9, 2004 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Ciprofloxacin Tablets USP, 250 mg, 500 mg and 750 mg. Shipment of this product is expected to begin immediately.